Here’s Why the Media DOESN’T Stand Up to Big Pharma Greed as Drug Prices Skyrocket in US
In an Op-Ed published in The LA Times, Vermont Senator and former Democratic presidential candidate Bernie Sanders, penned:
“One out of five Americans age 19 to 64 cannot afford their prescriptions. Hundreds of thousands of seniors cut their pills in half to stretch one month’s prescription into two. Meanwhile, the five largest drug companies made more than $50 billion in profits last year.
“The top 10 CEOs in the industry received a total of more than $327 million in compensation. They [Big Pharma] currently have 1,266 lobbyists on their payrolls in Washington, D.C., and 118 fighting for their priorities in Sacramento. They’ve made hundreds of millions in campaign contributions to politicians.”
Though rising prescription drug prices is a major health crisis nationwide, corporate media largely ignored the issue important to millions of Americans.
Latest News from Ring Of Fire Radio/Drug Safety News
- Johnson & Johnson Talc Lawsuits Move to New Jerseyby Levin Papantio Law November 15, 2021
U.S. Bankruptcy Judge Craig Whitley in Charlotte, North Carolina ordered that tens of thousands of lawsuits against Johnson & Johnson be moved to New […]
- Philips' CPAP Repair Plan Could Take A Year to Wrap Upby Levin Papantio Law November 8, 2021
Philips’ quarterly report offers encouraging words that the company’s CPAP repair and replacement program is “underway.” Some users will have to wait […]
- Syngenta Paraquat Cases Progress Toward a Bellwether Trialby Levin Papantio Law November 8, 2021
A late October hearing signaled movement toward trial for plaintiffs demanding compensation from the makers of paraquat weed killer, reports US Right to Know. […]
- Dangerous Bacteria in Better Homes and Gardens Essential Oil Infused Aromatherapy Room Spray Prompts Walmart Recallby Levin Papantio Law October 29, 2021
On October 22, 2021, Walmart announced it is recalling around 3,900 bottles of Better Homes and Gardens’ Essential Oil Infused Aromatherapy Room Spray with […]
- How the J & J Bankruptcy Could Affect Talc Cancer Lawsuitsby Levin Papantio Law October 23, 2021
Plaintiffs in talc cancer lawsuits against Johnson & Johnson have had a white-knuckle time of it after hearing the company’s plans to file bankruptcy. If […]
- Symptoms, Diagnosis, and Treatment of BIA-ALCLby Levin Papantio Law October 22, 2021
According to the U.S. Food and Drug Administration (FDA), by January of 2020, the government agency had received 733 medical device reports (MDRs) of breast […]
- Superior Court Judge Sets Dates for First U.S. Zantac Trialsby Levin Papantio Law October 6, 2021
Superior Court Judge Evelio Grillo for the County of Alameda, who oversees the California Ranitidine Product Cases Judicial Council Coordinated Proceedings […]
- Panel Considers Consolidating CPAP Lawsuitsby Levin Papantio Law October 6, 2021
As of September 28, 2021, a total of 93 class actions had been filed against Continuous Positive Air Pressure (CPAP) maker Philips Respironics. The Judicial […]
- Lawsuits Filed for CION Investment Corp. (CIC) Investment Lossesby Levin Papantio Law October 6, 2021
The Levin Papantonio Rafferty law firm currently represents customers in claims to recover their investment losses in CION Investment Corp. On Tuesday, October […]
- FDA Requires New Warnings for Xeljanz and Other Arthritis Medicines Due to Heart Risksby Levin Papantio Law September 18, 2021
The U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication (DSC) regarding the arthritis and ulcerative colitis drug Xeljanz (and Xeljanz […]
